About Avisi Technologies
Avisi Technologies is a company based in Philadelphia (United States) founded in 2017 by Brandon Kao and Rui Jing Jiang. Avisi Technologies has raised $15.7 million across 5 funding rounds from investors including Good Growth Capital, Ben Franklin Technology Partners and LSG Investments. Avisi Technologies operates in a competitive market with competitors including Glaukos, Novavax, SINTX, RevBio and Myra Vision, among others.
- Headquarter Philadelphia, United States
- Founders Brandon Kao, Rui Jing Jiang
-
Sectors
TechnologyHealthcare Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Avisi Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.7 M (USD)
in 5 rounds
-
Latest Funding Round
$10.7 M (USD), Series A
Feb 25, 2026
-
Investors
Good Growth Capital
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Avisi Technologies
Unlock access to complete
Unlock access to complete
Board Team
11 people
Leadership Team
4 people
Software Development Team
2 people
Operations Team
2 people
Unlock access to complete
Funding Insights of Avisi Technologies
Avisi Technologies has successfully raised a total of $15.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $10.7 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avisi Technologies
Avisi Technologies has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include Good Growth Capital, Ben Franklin Technology Partners and LSG Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in life sciences technologies.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Locked | Locked | Locked |
Investor details for Avisi Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avisi Technologies
Investment portfolio details for Avisi Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avisi Technologies
Detailed financials for Avisi Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avisi Technologies Comparisons
Peer comparison for Avisi Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avisi Technologies
Avisi Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Novavax, SINTX, RevBio and Myra Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of implants to treat glaucoma
|
|
| Locked | Locked | Locked |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| Locked | Locked | Locked |
Silicon nitride medical devices are manufactured for interbody fusion.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| Locked | Locked | Locked |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
Detailed competitors of Avisi Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avisi Technologies
Complete news archive for Avisi Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avisi Technologies
Avisi Technologies was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Avisi Technologies is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Rui Jing Jiang is the current CEO of Avisi Technologies. They have also founded this company.
Avisi Technologies is a funded company, having raised a total of $15.7M across 5 funding rounds to date.
Avisi Technologies was founded in 2017 in Philadelphia, United States. Nano-materials are developed by the company within the medical technology sector. An ultrathin nanoplate made of alumina is created as implant material for mid to late-stage glaucoma treatment. This work is conducted in collaboration with the University of Pennsylvania. A platform is provided to support these material developments and applications.
Avisi Technologies has 17 investors. Key investors include Good Growth Capital, Ben Franklin Technology Partners, LSG Investments, Accanto Partners, and Quaker Capital Investments.